Work

Potential Impact of Extending Surveillance Intervals for Patients With 1–2 Low-Risk Adenomas

Year: 2022

Type: article

Abstract: The 2020 US Multi-Society Task Force (USMSTF) guidelines on colonoscopy surveillance recommended the extension of surveillance intervals for patients with 1–2 low-risk adenomas (LRAs) to 7–10 years, longer than the 5–10 years recommended in 2012 by the same group.1,2 This recommendation was based on studies which showed the cumulative incidence of advanced neoplasia (AN) to be low, and similar to patients with a normal baseline colonoscopy.3,4 Subsequent studies have shown that while the incidence of colorectal cancer (CRC) is slightly increased in patients with 1–2 LRAs when compared to those with a normal baseline, there is no difference in CRC mortality.

Source: Gastro Hep Advances

DOI: 10.1016/j.gastha.2022.11.011

Authors: M. Trivedi, D. Mai, S. Gupta

Institutions: University of California San Diego, VA San Diego Healthcare System

Language: English

Topic: Colorectal Cancer Screening and Detection

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000